Azelastine hydrochloride Chemical Properties

Melting point:

225--2290C

storage temp. 

Inert atmosphere,Store in freezer, under -20°C

solubility 

DMSO: >10mg/mL

form 

powder

color 

white to off-white

Merck 

14,906

Stability:

Incompatible with strong oxidizing agents.

InChI

InChI=1S/C22H24ClN3O.ClH/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16;/h2-3,6-11,18H,4-5,12-15H2,1H3;1H

InChIKey

YEJAJYAHJQIWNU-UHFFFAOYSA-N

SMILES

C1(=O)C2=C(C=CC=C2)C(CC2=CC=C(Cl)C=C2)=NN1C1CCCN(C)CC1.[H]Cl

CAS DataBase Reference

79307-93-0(CAS DataBase Reference)

Safety Information

Hazard Codes 

Xn

Risk Statements 

22

RTECS 

TH9203900

HS Code 

2933992600

Toxicity

LD50 in male, female mice, male, female rats (mg/kg): 36.5, 35.5, 26.9, 30.3 i.v.; 56.4, 42.8, 43.2, 46.6 i.p.; 63.0, 54.2, 66.5, 59.6 s.c.; 124, 139, 310, 417 orally (Zechel)

Azelastine hydrochloride Usage And Synthesis

Description

Azelastine hydrochloride is an orally effective antihistamine useful in the treatment of asthma and nasal allergy. It appears to inhibit release of histamine, in addition to antagonizing its action.

Chemical Properties

White or almost white, crystalline powder.

Originator

Asta-Werke(Degussa) (W. Germany)

Uses

Orally active H1-hystamine receptor antagonist. Antihistaminic

Definition

ChEBI: The hydrochloride salt of azelastine.

brand name

Astelin (Medpointe); Optivar (Medpointe);AZEPTIN.

General Description

(±)-4-[(4-chlorophenyl)methyl]-2-(hexahydro-l-methyl-1H-azepin-4-yl)-l-(2H)-phthalazinone monohydrochloride (Optivar), is a whitecrystalline powder that is sparingly soluble in water,methanol, and propylene glycol and slightly soluble inethanol, octanol, and glycerine. The commercial preparationis available as a 0.05% sterile ophthalmic solution fortopical administration to the eyes. Each milliliter of azelastinesolution contains 0.5-mg azelastine hydrochlorideequivalent to 0.457 mg of azelastine base, the preservativebenzalkonium chloride (0.125 mg), and inactive ingredientsincluding disodium edetate dihydrate, hydroxypropylmethylcellulose,sorbitol solution, sodium hydroxide, andwater for injection. The solution has a pH of approximately5.0 to 6.5 and an osmolality of approximately 271to 312 mOsm/L.
The recommended dose of azelastine solution is 1 dropinstilled into each affected eye twice a day. This drugproduct is for ocular administration only and not for injectionor oral use. Absorption of azelastine following ocularadministration is relatively low (less than 1 ng/rnL).Absorbed drug undergoes extensive oxidative N-demethylationby CYP, and the parent drug and metabolite are eliminatedprimarily in the feces. The most frequently reportedadverse reactions are transient eye burning or stinging,headaches, and bitter taste. Azelastine solution should beused with caution during pregnancy or while nursing, becauseits safety has not been studied under these circumstances.

Biochem/physiol Actions

H1 histamine receptor antagonist; NF-kB activator.

Safety Profile

Poison by ingestion andintravenous routes. An experimental teratogen. Otherexperimental reproductive effects. When heated todecomposition it emits toxic fumes of NOx and HCl.

Azelastine hydrochloride(79307-93-0)Related Product Information

• Basic Violet 1
• Topotecan hydrochloride
• Benzyltrimethylammonium hydroxide
• Methylparaben
• Acetonitrile
• Methyl acrylate
• Methyl acetate
• Benzyltriethylammonium chloride
• Benzyltrimethylammonium chloride
• Benzyl bromide
• Benzyl chloride
• DIBENZYLTOLUENE
• 1-AdaMantanethylaMine
• Kresoxim-methyl
• N,N-Dimethylbenzylamine
• Methanol
• Paraquat dichloride
• Methyl